首页> 外文期刊>BMC Palliative Care >Pragmatic cluster randomised controlled trial of facilitated family case conferencing compared with usual care for improving end of life care and outcomes in nursing home residents with advanced dementia and their families: the IDEAL study protocol
【24h】

Pragmatic cluster randomised controlled trial of facilitated family case conferencing compared with usual care for improving end of life care and outcomes in nursing home residents with advanced dementia and their families: the IDEAL study protocol

机译:实用家庭病例会议与常规护理相比较的实用集群随机对照试验,旨在改善晚期痴呆症患者及其家人的临终护理和改善结局:IDEAL研究方案

获取原文
       

摘要

Care for people with advanced dementia requires a palliative approach targeted to the illness trajectory and tailored to individual needs. However, care in nursing homes is often compromised by poor communication and limited staff expertise. This paper reports the protocol for the IDEAL Project, which aims to: 1) compare the efficacy of a facilitated approach to family case conferencing with usual care; 2) provide insights into nursing home- and staff-related processes influencing the implementation and sustainability of case conferencing; and 3) evaluate cost-effectiveness. A pragmatic parallel cluster randomised controlled trial design will be used. Twenty Australian nursing homes will be randomised to receive either facilitated family case conferencing or usual care. In the intervention arm, we will train registered nurses at each nursing home to work as Palliative Care Planning Coordinators (PCPCs) 16?h per week over 18?months. The PCPCs’ role will be to: 1) use evidence-based ‘triggers’ to identify optimal time-points for case conferencing; 2) organise, facilitate and document case conferences with optimal involvement from family, multi-disciplinary nursing home staff and community health professionals; 3) develop and oversee implementation of palliative care plans; and 4) train other staff in person-centred palliative care. The primary endpoint will be symptom management, comfort and satisfaction with care at the end of life as rated by bereaved family members on the End of Life in Dementia (EOLD) Scales. Secondary outcomes will include resident quality of life (Quality of Life in Late-stage Dementia [QUALID]), whether a palliative approach is taken (e.g. hospitalisations, non-palliative medical treatments), staff attitudes and knowledge (Palliative Care for Advanced Dementia [qPAD]), and cost effectiveness. Processes and factors influencing implementation, outcomes and sustainability will be explored statistically via analysis of intervention ‘dose’ and qualitatively via semi-structured interviews. The pragmatic design and complex nature of the intervention will limit blinding and internal validity but support external validity. The IDEAL Project will make an important contribution to the evidence base for dementia-specific case conferencing in nursing homes by considering processes and contextual factors as well as overall efficacy. Its strengths and weaknesses will both lie in its pragmatic design. Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12612001164886 . Registered 02/11/2012.
机译:对晚期痴呆症患者的护理需要针对疾病轨迹并针对个人需求的姑息治疗方法。然而,护理院中的护理常常因沟通不畅和员工专业知识有限而受到损害。本文报告了IDEAL项目的协议,该协议旨在:1)将便利的家庭病例会议方法与常规护理方法的功效进行比较; 2)深入了解与护理院和员工相关的过程,从而影响案例会议的实施和可持续性; 3)评估成本效益。将使用一个实用的并行集群随机对照试验设计。澳大利亚将有20个疗养院被随机分配,以接受便利的家庭案例会议或常规护理。在干预部门,我们将培训每个疗养院中的注册护士,以在18个月的时间内每周16个小时作为姑息治疗计划协调员(PCPC)。 PCPC的角色将是:1)使用基于证据的“触发器”来确定案例会议的最佳时间点; 2)在家庭,多学科疗养院工作人员和社区卫生专业人员的最大参与下,组织,促进和记录案例会议; 3)制定并监督姑息治疗计划的实施; 4)对其他员工进行以人为本的姑息治疗培训。主要终点将是死者的家属在痴呆症终末期(EOLD)量表上评估的临终症状管理,舒适度和对护理的满意程度。次要结果将包括居民的生活质量(晚期痴呆的生活质量[QUALID]),是否采取姑息治疗(例如住院,非姑息治疗),员工态度和知识(晚期痴呆的姑息治疗[ qPAD]),以及成本效益。将通过对干预“剂量”的分析进行统计分析,并通过半结构化访谈进行定性分析,从统计角度探讨影响实施,成果和可持续性的过程和因素。务实的设计和干预的复杂性将限制盲目性和内部效度,但支持外部效度。 IDEAL项目将通过考虑过程和上下文因素以及整体功效,为老年痴呆症特定病例会议的证据基础做出重要贡献。它的优点和缺点都将在于其实用的设计。澳大利亚新西兰临床试验注册中心(ANZCTR)ACTRN12612001164886。注册于02/11/2012。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号